Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.9b00770
Abstract: TGR5 agonists are potential therapeutics for a variety of conditions including type 2 diabetes, obesity, and inflammatory bowel disease. After screening a library of chenodeoxycholic acid (CDCA) derivatives, it was determined that a range of…
read more here.
Keywords:
potency;
increase;
chenodeoxycholic acid;
methylation chenodeoxycholic ... See more keywords